TargetMol

TargetMol logo

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, specializing in chemical and biological research products and service to meet the research needs of global customers. With the help of fast and efficient global supply chain,professional and rigorous procurement process and timely dynamic news of products, you will save more time with less cost and lead in drug discovery and screening. We are equipped to meet an array of client’s requirements, varying from virtual screening to chemical structure optimization to the provision of commercial products. For further information on our products and services, take a look around our website.

Company Website

Product Listing

Bindarit 2 mg  | 98.48%

TargetMol

Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.

More Information Supplier Page

Bindarit 1 mL  | 98.48%

TargetMol

Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.

More Information Supplier Page

Bindarit 1 mg  | 98.48%

TargetMol

Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.

More Information Supplier Page

Bindarit 500 mg  | 98.48%

TargetMol

Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.

More Information Supplier Page

Bindarit 100 mg  | 98.48%

TargetMol

Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.

More Information Supplier Page

Bindarit 10 mg  | 98.48%

TargetMol

Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.

More Information Supplier Page

Bindarit 25 mg  | 98.48%

TargetMol

Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.

More Information Supplier Page

Bindarit 50 mg  | 98.48%

TargetMol

Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.

More Information Supplier Page

Bindarit 5 mg  | 98.48%

TargetMol

Bindarit displays specific inhibition against monocyte chemotactic proteins MCP-1/CCL2, MCP-3/CCL7 and MCP-2/CCL8.

More Information Supplier Page

Binimetinib 100 mg  | Purity Not Available

TargetMol

Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.

More Information Supplier Page

Binimetinib 200 mg  | Purity Not Available

TargetMol

Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.

More Information Supplier Page

Binimetinib 1 mL  | Purity Not Available

TargetMol

Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.

More Information Supplier Page

Binimetinib 10 mg  | Purity Not Available

TargetMol

Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.

More Information Supplier Page

Binimetinib 25 mg  | Purity Not Available

TargetMol

Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.

More Information Supplier Page

Binimetinib 50 mg  | Purity Not Available

TargetMol

Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.

More Information Supplier Page

Binimetinib 5 mg  | Purity Not Available

TargetMol

Binimetinib (MEK162, ARRY-162, ARRY-438162) is an orally available inhibitor of MEK1/2 (IC50: 12 nM) in a cell-free assay.

More Information Supplier Page

Binodenoson 1 mL  | 99.84%

TargetMol

Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].

More Information Supplier Page

Binodenoson 1 mg  | 99.84%

TargetMol

Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].

More Information Supplier Page

Binodenoson 5 mg  | 99.84%

TargetMol

Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].

More Information Supplier Page

Binodenoson 10 mg  | 99.84%

TargetMol

Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].

More Information Supplier Page

Binodenoson 25 mg  | 99.84%

TargetMol

Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].

More Information Supplier Page

Binodenoson 50 mg  | 99.84%

TargetMol

Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].

More Information Supplier Page

Binodenoson 100 mg  | 99.84%

TargetMol

Binodenoson is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].

More Information Supplier Page

Binucleine 2 5 mg  | Purity Not Available

TargetMol

Binucleine 2 is an isoform-specific and ATP-competitive inhibitor of Drosophila Aurora B kinase (Ki = 0.36 μM), a kinase involved in cell division. It is specific for Drosophila Aurora B kinase, inhibiting it in a dose-dependent manner, with minimal inhibition of human or X. laevis Aurora B kinases at concentrations up to 100 μM. Binucleine […]

More Information Supplier Page

Binucleine 2 50 mg  | Purity Not Available

TargetMol

Binucleine 2 is an isoform-specific and ATP-competitive inhibitor of Drosophila Aurora B kinase (Ki = 0.36 μM), a kinase involved in cell division. It is specific for Drosophila Aurora B kinase, inhibiting it in a dose-dependent manner, with minimal inhibition of human or X. laevis Aurora B kinases at concentrations up to 100 μM. Binucleine […]

More Information Supplier Page

Binucleine 2 100 mg  | Purity Not Available

TargetMol

Binucleine 2 is an isoform-specific and ATP-competitive inhibitor of Drosophila Aurora B kinase (Ki = 0.36 μM), a kinase involved in cell division. It is specific for Drosophila Aurora B kinase, inhibiting it in a dose-dependent manner, with minimal inhibition of human or X. laevis Aurora B kinases at concentrations up to 100 μM. Binucleine […]

More Information Supplier Page